enkephalin, methionine has been researched along with Kidney Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braczkowski, R; Cieśla, K; Huzarska, M; Romanowski, W; Zubelewicz, B | 1 |
| Beltz, MS; Bisignani, GJ; Jarowenko, MV; McLaughlin, PJ; Ordille, SD; Zagon, IS | 1 |
| Braczkowski, R; Plaza, J; Romanowski, W; Zubelewicz, B | 1 |
| Faith, RE; Miller, GC; Murgo, AJ; Nimeh, N; Plotnikoff, NP; Wybran, J | 1 |
1 trial(s) available for enkephalin, methionine and Kidney Neoplasms
| Article | Year |
|---|---|
The influence of interleukin-2 administration on met-enkephalins in patients with renal carcinoma.
Topics: Adult; Blood Pressure; Carcinoma, Renal Cell; Enkephalin, Methionine; Female; Heart Rate; Humans; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Radioimmunoassay | 1997 |
3 other study(ies) available for enkephalin, methionine and Kidney Neoplasms
| Article | Year |
|---|---|
Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.
Topics: Carcinoma, Renal Cell; Cell Division; Culture Techniques; Enkephalin, Methionine; Humans; Kidney Neoplasms; Opioid Peptides; Tumor Cells, Cultured | 1999 |
Decline of met-enkephalins concentration after interleukin-2 subcutaneous administration due to renal carcinoma.
Topics: Adult; Carcinoma, Renal Cell; Enkephalin, Methionine; Female; Humans; Immunotherapy; Injections, Subcutaneous; Interleukin-2; Kidney Neoplasms; Male; Middle Aged | 2000 |
Enkephalins and T-cell enhancement in normal volunteers and cancer patients.
Topics: Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Enkephalin, Methionine; Humans; Kidney Neoplasms; Lymphocyte Activation; Melanoma; Neoplasms; Reference Values; Sarcoma, Kaposi; T-Lymphocytes | 1987 |